AKT1 and esophageal squamous cell carcinoma: In particular, metformin has been found to hinder the migration and invasion of ESCC EC109 cells, as well as to suppress nuclear factor-κB activation, MMP-9 expression, and N-cadherin expression in a manner dependent on phosphorylated AKT.